CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Shanghai EpimAb Biotherapeutics Co., Ltd.

For profitWebsite ↗

Also known as: EpimAb Biotherapeutics (Suzhou)Co., Ltd. | Shanghai EpimAb Biotherapeutics Co., Ltd.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Nov 17, 2022

Timeline

2010s

Jun 1, 2015
Shanghai EpimAb Biotherapeutics Co., Ltd.— Founded

Drugs by trial phase (6 distinct, 7 trials)

Phase 2 (4 own, 0 via acquisition)

Phase 1 (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (7)

NCT05607498Lead sponsorPhase 1Nov 17, 2022
NCT05498389Lead sponsorPhase 1/Phase 2Oct 31, 2022
NCT05263180Lead sponsorPhase 1Apr 11, 2022
NCT05176665Lead sponsorPhase 1/Phase 2Oct 21, 2021
NCT04735575Lead sponsorPhase 1/Phase 2May 20, 2021
NCT04618393Lead sponsorPhase 1/Phase 2Dec 31, 2020
NCT03797391Lead sponsorPhase 1/Phase 2Dec 13, 2018

Details

Founded: Shanghai, CN Jun 1, 2015
Last known activity: Nov 17, 2022